acetylshikonin has been researched along with Cancer of Mouth in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, BH; Choi, YW; Jung, JE; Jung, YH; Kim, DJ; Lee, JH; Park, HR; Woo, BH | 1 |
Choi, YW; Kim, DJ; Lee, JH; Park, HR | 1 |
2 other study(ies) available for acetylshikonin and Cancer of Mouth
Article | Year |
---|---|
Acetylshikonin suppresses invasion of Porphyromonas gingivalis‑infected YD10B oral cancer cells by modulating the interleukin-8/matrix metalloproteinase axis.
Topics: Anthraquinones; Bacteroidaceae Infections; Cell Line, Tumor; Cells, Cultured; Epithelial-Mesenchymal Transition; Gene Expression; Humans; Interleukin-8; Matrix Metalloproteinases; Mouth Neoplasms; Porphyromonas gingivalis | 2018 |
Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; G2 Phase Cell Cycle Checkpoints; Humans; MAP Kinase Kinase 4; Metabolic Networks and Pathways; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species | 2016 |